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Type II Diabetes Mellitus
Drew Linardi RN BSN
Introduction
• The topic I have chosen for my 
poster presentation is type II 
diabetes mellitus: a case of beta cell 
underproduction and insulin 
resistance (Kahn, Cooper, & Del 
Prato, 2014). 
• The rationale for selecting this 
topic was to clearly illustrate the 
pathophysiological process of type 
II diabetes mellitus as well as the 
negative impact hyperglycemia has 
on clinical outcomes (Kahn et al., 
2014).
• I was personally motivated in 
selecting this topic as I am a type I 
diabetic patient who contracted my 
condition via a viral infection from 
a bee sting. I have been personally 
blessed with a fantastic 
endocrinologist whom together 
keeps my A1C level in the mid to 
upper five range. 
• Working in a cardiac recovery unit, 
patients are frequently observed 
having poor or worsening 
cardiovascular and vascular 
outcomes due to uncontrolled type 
II diabetes. 
• Type II diabetes presents itself in 
one of two ways (Kahn et al., 
2014).  First, beta cells within the 
pancreas are unable to produce 
adequate amounts of insulin to 
keep blood glucose levels regulated 
(Kahn et al., 2014). Second, insulin 
resistance occurs where 
individuals who are typically 
overweight or obese have been 
producing too much insulin due to
lessened sensitivity in appropriate 
cells (Kahn et al., 2014). Eventually 
the beta cells cannot keep up the 
excess insulin production and 
production declines despite there 
being an increased demand for it 
(Kahn et al., 2014).
• As of 2014, it was estimated that 
29 million individuals in the United 
States were diabetic with an 
additional 86 million afflicted with 
prediabetes (“CDC,” 2014). 
• A diagnosis of type II diabetes is 
made when a patient has two 
separate tests indicating an A1C of 
6.5 or higher (“MayoClinic,” 2018).
• Treatment of type II diabetes 
includes weight loss, proper diet, 
exercise, possible medication and 
insulin therapy, and frequent blood 
glucose monitoring (“MayoClinic,” 
2018). 
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Patient 
Presentation• Signs and symptoms of type II 
diabetes include increased thirst, 
increased hunger, dry mouth, 
frequent urination, unexplained 
weight loss, fatigue, blurred vision, 
numbness or tingling in the hands 
or feet, dry and itchy skin, and slow 
healing of cuts and sores 
(“Cleveland Clinic, “ 2018). 
• Type II diabetics can go into 
diabetic ketoacidosis exhibiting 
signs such as fruity breath however 
this is less likely to occur compared 
to type I diabetics (“Medline Plus, “ 
2018). Diabetic ketoacidosis is 
typically less severe in type II 
diabetics (“Medline Plus, “2018). 
Diabetic ketoacidosis is brought on 
in type II diabetics by medication 
noncompliance, or onset of 
infection, resulting in sustained 
uncontrolled hyperglycemia 
(“Medline Plus,” 2018). 
• Long term effects of uncontrolled 
type II diabetes include 
retinopathy, neuropathy, 
nephropathy, elevated coronary 
artery disease risk, elevated 
cerebrovascular disease risk, and 
elevated peripheral arterial disease 
risk (“Johns Hopkins Medicine, “ 
2018). 
A study was conducted evaluating 
patients undergoing noncardiac surgery 
from the years 2004 to 2013 
encompassing roughly 10.5 million 
individuals (Newman, Wilcox, Smilowitz, 
and Berger, 2018).
The study evaluated MACCE 
outcomes in diabetic patients versus 
nondiabetic patients (Newman et al., 
2018). MACCE outcomes where defined 
as major adverse cardiovascular and 
cerebrovascular events (Newman et al., 
2018).
The study found that diabetic 
patients exhibited a statistically 
significant increased likelihood of 
experiencing a MACCE event including all 
cause mortality, myocardial infarction, 
and ischemic stroke versus nondiabetic 
patients (Newman et al., 2018).
The increased risk of MACCE events 
in diabetic patients was supported with a 
p value of <0.001 (Newman et al., 2018). 
The study found that from 2004 to 2013 
the amount of diabetic patients 
presenting for surgery had increased 
significantly from the studies inception 
(Newman et al., 2018). 
Rehman and others found that 
patients presenting with ischemic stroke 
were more often found to have 
hyperglycemia and raised hemoglobin 
A1C than not (Rehman, Alam, & Rehman, 
2017). 
Hayward and others conducted a 
study evaluating 1,791 military veterans 
with type II diabetes and randomly 
assigned half the subjects to intensive 
glucose control and the other half to 
standard therapy (Hayward et al., 2015). 
The results revealed that individuals 
in the intensive glucose therapy group 
experienced significantly fewer major 
cardiovascular events than those 
assigned to the standard therapy group 
(Hayward et al., 2015).
Current projections have shown that 
by the year 2030 roughly 552 million 
individuals will have diabetes (Laakso & 
Kuusisto, 2014). 
As healthcare providers, it is 
imperative to reverse this trend and limit 
the micro and macrovascular 
complications of type II diabetes and 
insulin resistance (Laakso & Kuusisto., 
2014). 
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Implications for Care.
Conclusion
Type II diabetes mellitus and insulin 
resistance are complex intertwined 
conditions that involve some form of 
eight different pathophysiological 
abnormalities (Cersosimo, Triplitt, Solis-
Herrera, Mandarino, and DeFronzo, 
2018).
These eight mechanisms include 
decreased peripheral glucose uptake in 
mainly muscle combined with altered 
endogenous glucose production, 
increased free fatty acid lipolysis 
contributing to elevated glucose output, a 
reduction in peripheral glucose 
utilization combined with beta cell 
dysfunction (Cersosimo et al., 2018).    
Pathophysiology of Type II Diabetes Mellitus 
and Insulin Resistance.
Beta cells at first are able to increase 
insulin production but eventually are 
unable to keep up with the elevated 
demand (Cersosimo et al., 2018). At the 
same time, an inappropriate release of 
glucagon from the alpha cells of the 
pancreas occurs post-prandially 
(Cersosimo et al., 2018).  The combination 
of impaired insulin production and 
elevated glucagon secretion is known as the 
decreased incretin effect occurring in the 
gastrointestinal tract (Cersosimo et al., 
2018). The central nervous system also 
plays a major role in type II diabetes as the 
hypothalamus contributes to insulin 
resistance by impairing insulin’s capacity to 
suppress glucose production (Cersosimo et 
al., 2018).
These pathological mechanisms are 
more commonly known as the ominous 
octet leading to hyperglycemia in type II 
diabetes depicted above in figure 2 
(Cersosimo et al., 2018). 
In insulin resistance the kidneys 
increase rates of glucose reabsorption at 
times to levels of 220 to 250 mg/dl before 
reaching a maximum reabsorptive
capacity (Cersosimo et al., 2018). 
Once reabsorptive capacity is reached 
elevated blood glucose occurs in 
peripheral circulation  (Cersosimo et al., 
2018). 
The liver plays a major role in glucose 
regulation as it is the main organ 
responsible for glucose uptake after meal 
consumption (Cersosimo et al., 2018).
Individuals afflicted with type II 
diabetes have reduced hepatic glucose 
uptake post-prandially resulting in elevated 
blood glucose levels (Cersosimo et al., 
2018).
Pathophysiology continued. 
Figure 1 Type II Diabetes Symptoms & Warning Signs (Lupo D.C., 2018). 
With an increasingly overweight and 
obese population insulin resistance I 
becoming more commonplace (Kahn et 
al., 2014). 
Insulin resistance and obesity often 
times go hand in hand when it comes to 
type II diabetes (Kahn et al., 2014). There 
is a feedback loop that exists between 
beta cells and insulin sensitive tissues 
(Kahn et al., 2014). 
Insulin released by the beta cells 
facilitates the uptake of glucose, fatty 
acids, and amino acids (Kahn et al., 
2014). 
The tissue of overweight and obese 
individuals becomes less sensitive to 
insulin increasing the demand on the 
beta cells to produce greater amounts of 
insulin to maintain normal blood glucose 
levels (Kahn et al., 2014). 
Over time the beta cells fatigue and 
can no  longer keep up with the 
increased demand for insulin production  
resulting in hyperglycemia (Kahn et al., 
2014). This is a frequent occurrence in 
obese and overweight individuals which 
can be rectified with weight loss (Kahn et 
al., 2014). 
As of 2018, nearly 70% of Americans 
are either overweight or obese (“AHA,” 
2018). 
Obesity is defines as being at or 
greater than 20% of an individuals ideal 
weight (“AHA,” 2018).
Currently there are nearly 13 million 
children ages 2-19 who are obese with 
an additional 11 million classified as 
overweight (“AHA,” 2018). 
The figures yield a total of 23.9 
million children qualifying as either 
overweight or obese (‘AHA, “ 2018).
Roughly 35% of adults in the United 
States qualify as obese totaling 78 million 
individuals (“AHA, “ 2018).
Individuals qualifying as overweight 
or obese are at increased risk of 
developing diabetes, heart disease, 
hypertension, and stroke (“AHA, “ 2018). 
As healthcare evolves to a primary 
prevention based focus individuals will 
need counseling regarding ideal body 
weight, portion control, prevention of 
obesity, as well as the risks of 
concomitant conditions such as diabetes 
and heart disease ( Macha & McDonough, 
2012).  
• Mr. R is a 59 year old 
Hispanic-American male 
presenting to the health 
clinic with complaints of 
fatigue, thirst, and 
increased appetite times 
three weeks despite 
eating, drinking, and 
sleeping more than usual.
• Upon a complete history 
and physical examination 
Mr. R is diagnosed with 
type II diabetes. Mr. R is 
obese with a BMI of 32, 
hypertensive with a BP of 
172/104, has a sedentary 
lifestyle, accucheck of 262, 
and a HGA1c of 10.3 
(“NIDDK,” 2018).  
Risk Factors
• Mr. R has several risk 
factors including obesity, 
hypertension, age, 
Hispanic ethnicity, and a 
sedentary lifestyle 
(‘NIDDK,’ 2018).
• A definitive diagnosis of 
type II diabetes can be 
made after Mr. R’s 
HGBA1c registers at 10.3 
and his fingerstick shows 
a blood glucose of 253 
(Accu-Check,” 2018).   
Figure 2 Ominous Octet and Hyperglycemia (Cersosimo et 
al., 2018).
